Related Experiment Video
Updated: Jan 27, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
A multifaceted approach for analyzing complex phenotypic data in rodent models of autism
Ishita Das1, Marcel A Estevez1, Anjali A Sarkar1
1MindSpec Inc., 8280 Greensboro Drive, Suite 150, McLean, VA 22102 USA.
This study presents a bioinformatics resource for autism spectrum disorder (ASD) models, detailing common phenotypes and environmental factors in rodent research. It also identifies potential pharmaceutical treatments for ASD symptoms.
Area of Science:
- Neuroscience
- Genetics
- Bioinformatics
Background:
- Autism Spectrum Disorder (ASD) is a complex, multifactorial condition with known genetic risk factors, but the role of environmental influences remains unclear.
- Existing research on ASD animal models often lacks a centralized, comprehensive overview of methodologies and findings.
Purpose of the Study:
- To create a bioinformatics resource cataloging genetic and environmentally induced models of ASD.
- To analyze research trends, identify key phenotypes, and evaluate therapeutic interventions in ASD animal models.
Main Methods:
- Development of a shared annotation platform for ASD models.
- Analysis of 787 publications to identify frequently studied phenotypes in rodent models.
- Examination of environmental inducers (e.g., valproic acid, lipopolysaccharide) and rescue models for pharmaceutical efficacy.
Main Results:
- Identified the top 30 phenotypes in rodent ASD models, including social behavior deficits, repetitive behaviors, anxiety, and seizures.
- Highlighted gestational valproic acid exposure and maternal immune activation as prominent environmental inducers.
- Evaluated 24 pharmaceutical agents for their potential to mitigate ASD-relevant symptoms in various models.
Conclusions:
- The bioinformatics resource provides a valuable tool for comparing ASD models and understanding research trends.
- Insights into common phenotypes and environmental factors can guide future ASD research.
- The study identifies promising pharmaceutical candidates for therapeutic development in ASD.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Statistical Methods for Analyzing Epidemiological Data

